Business Standard

Chinese tech firms forced into 'blood listings' as capital dries up

Public offerings at slashed valuations could translate into losses for venture capitalists in late funding rounds

Chinese firms
Premium

Chinese firms

Reuters Shanghai
A growing number of Chinese tech start-ups, once the darlings of equity markets, are willing to list shares publicly in China at valuations lower than during private funding rounds in so-called blood listings.
 
Unlike tech sector woes elsewhere, triggered mainly by rising interest rates, the misery in China comes from frothy tech markets and disruptions from harsh COVID-19 restrictions.
 
Public offerings at slashed valuations could translate into losses for venture capitalists in late funding rounds.
 
CloudWalk Technology Co, hailed as one of China's "Four Dragons" in Artificial Intelligence (AI), debuts in Shanghai on Friday following an initial public offering that

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 26 2022 | 11:21 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com